Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 3/26/2013

For months, experts have voiced disagreement over whether the blockbuster atrial fibrillation drug Pradaxa carries greater risks for serious internal bleeding than traditional warfarin.

The drug has now been used by millions of patients in over 70 countries since it was released in 2010. Therefore, the potential for injury increases each day until there is a definite identification of its safety or dangers.

Pradaxa is a blood thinner used to prevent strokes in patients with atrial fibrillation. Although all blood thinners have the potential to cause internal bleeding, Pradaxa has no antidote which doctors can use to stop the bleeding as with other anticoagulants.

To the surprise of no one, research sponsored by the company who sells Pradaxa, Boehringer Ingelheim, concludes it is highly effective at preventing strokes, and as safe or safer than warfarin.

However, it is the repeated endorsement of Pradaxa as safe by the FDA that has many experts scratching their heads. While doctors remain cautious about prescribing it, the agency has stated on multiple occasions that Pradaxa is as safe as warfarin.

Recently, the Institute for Safe Medication Practices re-opened the debate when they ranked blood thinners like Pradaxa among the most dangerous drugs available. They also found in a review of FDA side effect reports that patients suffering Pradaxa bleeding were nearly 5 times as likely to die than those with bleeding while taking warfarin.

Now, researchers from the University of Illinois at Chicago have presented findings to the American College of Cardiology which warn that the data being used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought*.

Amid the conflicting reports, over 260 patients have filed a Pradaxa lawsuit after suffering internal bleeding on the drug. Most cases have been consolidated to a special federal court in Illinois. Lawyers are still helping those affected file claims.

If you or a family member suffered internal bleeding after taking Pradaxa, you are urged to speak with a lawyer about your legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

Contact us today for more information on the research, side effects and litigation news related to Pradaxa, or to speak with a lawyer about your case.

*dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting